Summary Investigations were carried out on two lines of human melanomas (MF; n = 12 and EE; n = 13) xenografted in nude mice. The tumours were characterised by a similar vascular supply but showed a pronounced difference in the rate of volume growth and in the radiobiologically hypoxic fraction. The distribution of ATP, glucose and lactate in the tumours was investigated using quantitative bioluminescence and single photon imaging. Concentrations of the metabolites were obtained as global values for the entire tumour mass, in regions with densely packed, structurally intact tumour cells ('viable zones'), in areas with necrosis, stromal cells and fibrous material ('necrotic zones') and in adjacent normal tissue. In all melanomas investigated glucose concentrations were significantly lower and lactate concentrations were significantly higher than in normal tissue. In contrast, no significant differences for ATP were detected. ATP and glucose concentrations were significantly less in necrotic than in viable tumour zones, whereas lactate concentrations were nearly equal in these tumour parts. Corresponding results were obtained in central versus peripheral tumour zones. There was no dependency of global or regional metabolite concentrations on tumour size within the volume range 110-1470 mm3. Based on this lack of dependency, metabolic concentrations were averaged over the whole tumour size range. Metabolite concentrations were not significantly different either globally or regionally between the two tumour entities investigated, a finding which held true for all three metabolites registered. Thus, metabolite distributions apparently mirror the similarity in vascularity of MF and EE melanomas rather than reflecting intrinsic properties with regard to tumour growth rates or susceptibility to radiation.
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The significance of pathophysiological parameters for prediction of the biological and therapeutic behaviour of tumours is subject to ongoing debates in cancer research. A large variety of partially confficting results has been documented by a number of scientific groups depending, among other factors, on the respective tumour model, the registered biological and physiological parameters, the treatment modality or the therapeutic end point.
Clinical studies have identified oxygen tension measured with polarographic needle electrodes as a predictive parameter for the outcome of radiation therapy in head and neck cancer and cervix cancer (Gatenby et al., 1988; Hockel et al., 1991 Hockel et al., , 1993 Vaupel et al., 1991) . Although no data on blood perfusion or vascular density were accessible in those investigations, it can be concluded from numerous other reports (reviewed in Vaupel et al., 1989) that differences in nutritive supply accounted for the variations in the oxygenation status of those tumours in patients. In a comprehensive study on human tumour xenografts, Kallinowski et al. (1989) found that the growth rate of a variety of different tumour entities was positively correlated with tumour blood flow, and that therapeutically relevant parameters of the metabolic micromilieu largely depended on the efficacy of tumour perfusion. Unfortunately, no data on the responsiveness to treatment of those xenografted tumours were available to enable a direct comparison between physiological and therapeutical parameters.
In an extensive study on growth kinetics, vascular morphology as well as radio-and thermosensitivity, Rofstad et al. have characterised the biology and therapeutic responsiveness of two types of human melanoma xenografts Brustad, 1981, 1986; Solesvik et al., 1982 Solesvik et al., , 1984 Rofstad, 1984 Rofstad, , 1989a (Solesvik et al., 1982; Rofstad, 1984 Rofstad, , 1989b .
Metabolic mapping, in particular geographical mapping of ATP, using quantitative bioluminescence and single photon imaging has generated metabolite distributions that closely reflected the oxygenation status and the efficacy of microcirculation in various tumour types (Kroeger et al., 1991; Kuhnle et al., 1992; Walenta et al., 1992; Schaefer et al., 1993 could be registered within distinct tissue areas, i.e. within viable tumour regions, within necrotic and stromal areas and in adjacent normal tissue.
Materials and methods
Investigations were carried out on 12 MF and 13 EE melanomas that were derived from lymph node metastases of patients and xenografted in female BALB/c-nu/nu/BOM mice (Solesvik et al., 1982 (Solesvik et al., , 1984 Rofstad, 1984) . The tumours were implanted s.c. into the flanks of the nude mice and were used for measurements at volumes ranging from 110 to 1470mm3 as determined with the caliper method. Tumour-bearing animals were kept under standardised conditions at the Norwegian Radium Hospital as described previously (Solesvik et al., 1982) . At certain sizes tumours were rapidly frozen in situ by contact with a brass block that was precooled in liquid nitrogen. After excision of the entire tumour mass including adjacent muscle and skin, the samples were put on dry ice and were immediately shipped to the Pathophysiology Division at the University of Mainz. There, tumours were sealed in airtight bags to prevent freeze-drying and were kept at -80°C until measurement. The distribution of metabolite concentrations within the tumours was assessed by single photon imaging and quantitative bioluminescence (Mueller-Klieser et al., 1988; Walenta et al., 1990; Mueller-Klieser and Walenta, 1993) . For measurement, cryosections made from the frozen tumours were adhered to the upper side of a cover glass. The cover glass was laid upside down upon a glass slide with a rectangular casting mould. The mould was filled with a frozen enzyme solution. The solution contained luciferase and other enzymes that link the substrate of interest to the luciferase light reaction. Different mixtures of enzymes and luciferases had to be used for determination of ATP, glucose, and lactate. Applying these enzyme solutions to serial sections, the metabolites could be determined at quasi-identical locations within the tumours.
The luciferase reaction with light emission started by raising the temperature of the whole array above the melting point by positioning the glass slides into a thermostated chamber on a microscope stage. The spatial distribution of the bioluminescence intensity within the tissue section was measured directly using an appropriate microscope (Axiophot, Zeiss, Oberkochen, Germany) and an imaging photon counting system (ARGUS 100, Hamamatsu, Herrsching, Germany).
After calibration with appropriate standards, two-dimensional density distributions were obtained representing the distribution of ATP, glucose, or lactate in absolute volumerelated tissue concentrations (pmol g-' wet weight). These values were routinely confirmed by independent measurements with high performance liquid chromatography (HPLC) and enzymatic standard assays respectively. 
Results
As in previous studies with bioluminescence imaging in various types of tumours, metabolite distributions measured in MF and EE human melanoma xenografts were very heterogeneous and partially reflected the chaotic histological architecture of the malignancies. As mentioned in Materials and methods, the data of all tumours were pooled for each xenograft type and expressed as mean ± s.d. No significant differences between the ATP concentrations averaged over the whole tumour tissue and the adjacent normal tissue were found in the MF and EE xenografts (Figure la) . Concentration values of glucose were significantly less in the tumour than in the adjacent normal tissue (Figure lb) . In contrast, opposing results were obtained for the distribution of lactate (Figure 1c) . Across the two tumour lines mean concentrations of all three metabolites in corresponding tissue areas were very similar. Only ATP values obtained in adjacent normal tissue were significantly different between MF and EE xenografts (P < 0.05).
ATP and glucose concentrations were significantly less in necrotic than in viable tumour areas, whereas lactate concentrations were nearly equal in these tumour parts. This was true in both MF and EE melanomas, as demonstrated in Figure 2a -c. Only for EE xenografts, the lactate concentrations showed a weak significant difference between viable and necrotic tumour parts (P < 0.05). As described above for values averaged over the entire tumour mass, statistically significant differences between MF and EE tumours were not seen for any of the three metabolites (P>0.1).
The evaluation of metabolite concentrations in peripheral vs central tumour areas resulted in data shown in Figure 3 . ATP and glucose concentrations were significantly less in central as compared with peripheral zones. No differences were found for lactate, although there was a tendency for higher values in the tumour centre. These findings were obtained in both MF and EE melanomas. Significant differences between the two tumour lines were not registered for any of the metabolites.
Since ATP, glucose and lactate concentrations obtained in the tumour areas showed no significant differences between the two melanoma lines investigated, the values of single tumours from the two entities were pooled for each metabolite and each mode of determination and were investigated for their dependence on tumour size. Figure 4 shows that there was no correlation between ATP, glucose and lactate concentrations obtained in whole tumour areas of single malignancies and tumour volume. As indicated by Spearman's correlation coefficient, no size dependencies were obvious for the concentrations of the three metabolites in viable and necrotic tumour regions or in normal tissue. An example is illustrated in Figure 5 showing ATP concentrations in viable (open symbols) and necrotic (solid symbols) tumour areas as a function of tumour volume.
Discussion
The results of the present study clearly show that there is no statistically significant or biologically relevant difference in (0) (Kallinowski et al., 1989) . In those tumours, high blood flow rates were associated with high metabolic turnover rates and rapid tumour growth. Despite high oxygen consumption rates, the oxygenation status was best in cancers with high-flow rates and fast growth, whereas substantial hypoxia with an oxygen pressure smaller than 5 mmHg was found only in poorly perfused malignancies. The findings of the present investigation suggest that tumours can differ greatly in their growth rate, although their situation with regard to vascular supply and metabolic milieu may be very similar. Obviously, blood supply meets the requirements for the unrestricted expression of intrinsic growth properties in both the tumour entities studied. In such a case, neither vascular parameters, nor data on blood perfusion or the metabolic state of the tumours would allow for a prediction of the rate of tumour expansion. The conclusion is supported by the finding, that EE and There is a striking difference in the radiobiologically hypoxic fraction of the two melanoma lines that cannot be explained on the basis of the present data. Although oxygen tension values in these tumours are presently unknown, the congruity of vascular density and metabolite distributions in the two melanoma types argues against profound differences in tumour oxygenation. This conclusion is strongly supported by previous investigations comparing tissue oxygenation of various solid tumours as quantified by cryospectrophotometry with intratumoral concentrations of ATP measured with bioluminescence . ATP was positively correlated with tissue oxygenation status across the different tumour lines in that experimental series. Intermediate hypoxia can probably not explain the apparent discrepancy between radiobiological hypoxia and metabolic milieu in these tumours since recent data have indicated that human melanoma xenografts do not show significant transient perfusion (Tufto and Rofstad, 1995) . On the basis of the present data one can assume that the metabolic micromilieu, i.e. the tissue concentration of oxygen and metabolites, is identical in both xenograft types. Therefore, the striking differences in the radiobiologically hypoxic fraction and the volume growth rate cannot be related to the vascular supply and must be explained by differences in the intrinsic properties of both tumours.
The bioluminescence method only allows for the measurement of steady state concentrations of metabolites. Thus, one possible explanation could be an intrinsically different metabolic turnover rate in both tumour types, which cannot be registered with the bioluminescence method. This explanation is in accordance with the volume growth rate in vivo and the cell growth rate in vitro. In addition, tumour cells in MF xenografts with lower metabolic turnover rates may survive hypoxic supply conditions for a longer time, leading to a higher radiobiologically hypoxic fraction as compared with EE tumours. The major advance in using metabolic imaging with bioluminescence as compared with previous approaches is the accessibility of structure-associated information on the functional state of biological tissue. In most cases, the technique allows for a highly resolved distinction between data acquired in malignancies and values measured in surrounding normal tissue. The concentrations of ATP and glucose were significantly lower in necrotic tumour regions with stromal elements as compared with areas with densely packed viable cancer cells, whereas lactate concentrations were equal or showed only a weak difference in these zones. Consequently, the distribution of ATP and glucose mirrored the geometry of these two 'classes' of tumour regions contrasted by lactate distributions that seemed to be relatively unrelated to the tissue architecture. Accordingly, the finding of significantly less ATP and glucose in the tumour centre compared with the periphery may reflect a different proportion of necrotic tissue in outer and inner tumour regions. Preliminary data obtained with the bioluminescence technique in biopsies of cervical cancers are indicative of structure-related patterns of all three metabolites in those malignancies (Mueller-Klieser et al., 1994) . Considering the regional evaluation of metabolites, the absence of any significant difference in the global metabolite concentrations between the two melanoma lines is consistent with the determination of similar necrotic fractions in these cancers (Solesvik et al., 1982) .
The present study documents no significant changes of the measuring parameters as a function of tumour size. This result may indicate no change in the proportion of necrotic vs viable tissue as the tumours increase in, volume. On the other hand, a relatively high ATP content in the necrotic region is indicative of some residual metabolic activity in those areas. Investigations on multicellular tumour spheroids have also revealed such a residual metabolic turnover in regions that may be identified as being necrotic by histological criteria . Taking into account the absence of correlation, it seems reasonable to calculate averages irrespective of tumour volume for the parameters considered here.
In conclusion, quantitative bioluminescence with single photon imaging offers the possibility of regional and structure-related evaluation of metabolite concentrations in biological tissue. The application of this technique in two lines of human melanoma xenografts with similar vascularity, yet different growth rates and different. radiobiologically hypoxic fractions resulted in metabolite distributions that were not statistically different. Thus, the measured metabolite concentrations reflect the efficiency of tumour blood perfusion and do not necessarily predict intrinsic growth behaviour or therapeutic sensitivity of tumours.
